Johnson Investment Counsel’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,315
Closed -$429K 677
2023
Q1
$429K Hold
5,315
0.01% 490
2022
Q4
$398K Sell
5,315
-700
-12% -$49.8K 0.01% 501
2022
Q3
$388K Sell
6,015
-123
-2% -$8.52K 0.01% 481
2022
Q2
$425K Sell
6,138
-95
-2% -$7.05K 0.01% 479
2022
Q1
$479K Buy
6,233
+2,988
+92% +$215K 0.01% 477
2021
Q4
$248K Hold
3,245
﹤0.01% 595
2021
Q3
$240K Buy
3,245
+150
+5% +$11.2K ﹤0.01% 585
2021
Q2
$206K Sell
3,095
-55
-2% -$3.68K ﹤0.01% 608
2021
Q1
$234K Buy
3,150
+217
+7% +$16.5K ﹤0.01% 557
2020
Q4
$214K Buy
+2,933
New +$207K ﹤0.01% 562

Other funds holding HOLX

Johnson Investment Counsel's HOLX Position: Q2 2023 in Review

Johnson Investment Counsel sold out of Hologic (HOLX) in Q2 2023, closing a stake of 5,315 shares — an estimated $429K sold.

Johnson Investment Counsel first reported a position in HOLX in Q4 2020 and held it in 10 quarters. The position peaked at $479K in Q1 2022. 713 funds tracked by Wall St. Rank hold HOLX as of Q2 2023.

  • Johnson Investment Counsel reported no remaining Hologic position as of Q2 2023 after selling out during the quarter.
  • Johnson Investment Counsel sold 5,315 Hologic shares in Q2 2023, an estimated $429K.
  • Johnson Investment Counsel first reported a position in Hologic in Q4 2020 and held it in 10 quarters.
  • Johnson Investment Counsel's Hologic position peaked at $479K in Q1 2022.
  • 713 funds tracked by Wall St. Rank held Hologic as of Q2 2023.

Based on Johnson Investment Counsel's 13F filing for Q2 2023, filed 10 Aug 2023.